FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2893741908> ?p ?o ?g. }

• W2893741908 abstract "Visinin-like protein-1 (VILIP-1) and chitinase-3-like protein 1 (CHI3L1 or YKL-40) in cerebrospinal fluid (CSF) are newly discovered markers indicating neuronal damage and microglial activation, respectively. Phosphorylated tau (p-tau) reflects the neuropathology of Alzheimer's disease (AD) and is useful as diagnostic markers for AD. However, it is unknown whether these biomarkers have similar or complementary information in AD.We stratified 121 participants from the Alzheimer's Disease Neuroimaging Initiative (ADNI) database into cognitively normal (CN), stable mild cognitive impairment (sMCI), progressive MCI (pMCI), and dementia due to AD. Analysis of covariance (ANOVA) and chi-square analyses, Spearman correlation, and logistic regression models were performed to test the demographic, associations between biomarkers, and diagnostic accuracies, respectively. Linear mixed-effects models were used to evaluate the effects of CSF amyloid-β (Aβ) on above biomarkers within diagnostic groups, the combination of diagnostic group and Aβ status as predictor, and CSF biomarkers as predictors of AD features, including cognition measured by Mini-Mental State Examination (MMSE) and brain structure and white matter hyperintensity (WMH) measured by magnetic resonance imaging (MRI).P-tau, VILIP-1, and YKL-40 were all predictors of AD diagnosis, but combinations of biomarkers did not improve the diagnostic accuracy (AUC 0.924 for p-tau, VILIP-1, and YKL-40) compared to p-tau (AUC 0.922). P-tau and VILIP-1 were highly correlated (r = 0.639, p < 0.001) and strongly associated with Aβ pathology across clinical stages of AD, while YKL-40 was correlated with Aβ pathology in CN and AD groups. VILIP-1 was associated with acceleration of cognitive decline, hippocampal atrophy, and expansion of ventricles in longitudinal analyses. YKL-40 was associated with hippocampal atrophy at baseline and follow-up, while p-tau was only associated with worsening WMH at baseline.CSF levels of p-tau, VILIP-1, and YKL-40 may have utility for discriminating between cognitively normal subjects and patients with AD. Increased levels of both VILIP-1 and YKL-40 may be associated with disease degeneration. These CSF biomarkers should be considered for future assessment in the characterization of the natural history of AD." @default.
• W2893741908 created "2018-10-05" @default.
• W2893741908 creator A5004968642 @default.
• W2893741908 creator A5006091170 @default.
• W2893741908 creator A5009612708 @default.
• W2893741908 creator A5026681917 @default.
• W2893741908 creator A5056450584 @default.
• W2893741908 creator A5066116388 @default.
• W2893741908 creator A5091097481 @default.
• W2893741908 date "2018-09-10" @default.
• W2893741908 modified "2023-10-17" @default.
• W2893741908 title "Cerebrospinal fluid phosphorylated tau, visinin-like protein-1, and chitinase-3-like protein 1 in mild cognitive impairment and Alzheimer’s disease" @default.
• W2893741908 cites W1412043633 @default.
• W2893741908 cites W1523320996 @default.
• W2893741908 cites W1841850981 @default.
• W2893741908 cites W1931861387 @default.
• W2893741908 cites W1966720891 @default.
• W2893741908 cites W1977493393 @default.
• W2893741908 cites W1998025612 @default.
• W2893741908 cites W2008301592 @default.
• W2893741908 cites W2033805494 @default.
• W2893741908 cites W2043816787 @default.
• W2893741908 cites W2070448139 @default.
• W2893741908 cites W2070698367 @default.
• W2893741908 cites W2078097676 @default.
• W2893741908 cites W2082665846 @default.
• W2893741908 cites W2103825172 @default.
• W2893741908 cites W2110603456 @default.
• W2893741908 cites W2111420081 @default.
• W2893741908 cites W2113456839 @default.
• W2893741908 cites W2124361740 @default.
• W2893741908 cites W2155180180 @default.
• W2893741908 cites W2158169875 @default.
• W2893741908 cites W2167840686 @default.
• W2893741908 cites W2171625517 @default.
• W2893741908 cites W2198002938 @default.
• W2893741908 cites W2205427262 @default.
• W2893741908 cites W2257675936 @default.
• W2893741908 cites W2463219262 @default.
• W2893741908 cites W2473313434 @default.
• W2893741908 cites W2518545320 @default.
• W2893741908 cites W2752044101 @default.
• W2893741908 cites W2787534295 @default.
• W2893741908 cites W4210537619 @default.
• W2893741908 cites W4211156109 @default.
• W2893741908 doi "https://doi.org/10.1186/s40035-018-0127-7" @default.
• W2893741908 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6161434" @default.
• W2893741908 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30311914" @default.
• W2893741908 hasPublicationYear "2018" @default.
• W2893741908 type Work @default.
• W2893741908 sameAs 2893741908 @default.
• W2893741908 citedByCount "39" @default.
• W2893741908 countsByYear W28937419082019 @default.
• W2893741908 countsByYear W28937419082020 @default.
• W2893741908 countsByYear W28937419082021 @default.
• W2893741908 countsByYear W28937419082022 @default.
• W2893741908 countsByYear W28937419082023 @default.
• W2893741908 crossrefType "journal-article" @default.
• W2893741908 hasAuthorship W2893741908A5004968642 @default.
• W2893741908 hasAuthorship W2893741908A5006091170 @default.
• W2893741908 hasAuthorship W2893741908A5009612708 @default.
• W2893741908 hasAuthorship W2893741908A5026681917 @default.
• W2893741908 hasAuthorship W2893741908A5056450584 @default.
• W2893741908 hasAuthorship W2893741908A5066116388 @default.
• W2893741908 hasAuthorship W2893741908A5091097481 @default.
• W2893741908 hasBestOaLocation W28937419081 @default.
• W2893741908 hasConcept C117220453 @default.
• W2893741908 hasConcept C126322002 @default.
• W2893741908 hasConcept C142724271 @default.
• W2893741908 hasConcept C143998085 @default.
• W2893741908 hasConcept C151956035 @default.
• W2893741908 hasConcept C15744967 @default.
• W2893741908 hasConcept C16568411 @default.
• W2893741908 hasConcept C169760540 @default.
• W2893741908 hasConcept C2524010 @default.
• W2893741908 hasConcept C2778373026 @default.
• W2893741908 hasConcept C2778670691 @default.
• W2893741908 hasConcept C2779134260 @default.
• W2893741908 hasConcept C2779483572 @default.
• W2893741908 hasConcept C2779651940 @default.
• W2893741908 hasConcept C2780130745 @default.
• W2893741908 hasConcept C2781197716 @default.
• W2893741908 hasConcept C2984863031 @default.
• W2893741908 hasConcept C33923547 @default.
• W2893741908 hasConcept C502032728 @default.
• W2893741908 hasConcept C55493867 @default.
• W2893741908 hasConcept C58693492 @default.
• W2893741908 hasConcept C71924100 @default.
• W2893741908 hasConcept C86803240 @default.
• W2893741908 hasConceptScore W2893741908C117220453 @default.
• W2893741908 hasConceptScore W2893741908C126322002 @default.
• W2893741908 hasConceptScore W2893741908C142724271 @default.
• W2893741908 hasConceptScore W2893741908C143998085 @default.
• W2893741908 hasConceptScore W2893741908C151956035 @default.
• W2893741908 hasConceptScore W2893741908C15744967 @default.
• W2893741908 hasConceptScore W2893741908C16568411 @default.
• W2893741908 hasConceptScore W2893741908C169760540 @default.
• W2893741908 hasConceptScore W2893741908C2524010 @default.
• W2893741908 hasConceptScore W2893741908C2778373026 @default.
• W2893741908 hasConceptScore W2893741908C2778670691 @default.

• next